STOCK TITAN

Milestone Pharmaceuticals to Present at the Canaccord Genuity 40th Annual Growth Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Rhea-AI Summary

Milestone Pharmaceuticals Inc. (Nasdaq: MIST) announced that CEO Joseph Oliveto will present at the Canaccord Genuity 40th Annual Growth Conference on August 13, 2020, at 1:00 PM ET. The event will take place virtually, and a live webcast will be available on Milestone's website. An archived replay will also be accessible for 30 days post-presentation. Milestone focuses on developing cardiovascular medicines and operates in both Canada and the U.S. For more details, visit www.milestonepharma.com.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – MIST

-1.79%
1 alert
-1.79% News Effect

On the day this news was published, MIST declined 1.79%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

MONTREAL and CHARLOTTE, N.C., Aug. 6, 2020 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Joseph Oliveto, President and Chief Executive Officer, will present at the Canaccord Genuity 40th Annual Growth Conference on Thursday, August 13, 2020 at 1:00 PM ET. The conference will be held in a virtual meeting format.

A live webcast of the presentation can be accessed in the News & Events section of Milestone's website at www.milestonepharma.com. An archived replay of the webcast will be available on the same website for approximately 30 days following the presentation.

About Milestone Pharmaceuticals

Milestone Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines. Milestone Pharmaceuticals operates in Canada and the United States. For more information, visit www.milestonepharma.com and follow the Company on Twitter at @MilestonePharma.

Contact

David Pitts
Argot Partners
212-600-1902
david@argotpartners.com

(PRNewsfoto/Milestone Pharmaceuticals)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/milestone-pharmaceuticals-to-present-at-the-canaccord-genuity-40th-annual-growth-conference-301107132.html

SOURCE Milestone Pharmaceuticals, Inc.

FAQ

What is the date of Milestone Pharmaceuticals' presentation at the Canaccord Genuity conference?

Milestone Pharmaceuticals will present at the Canaccord Genuity 40th Annual Growth Conference on August 13, 2020.

Who is presenting for Milestone Pharmaceuticals at the conference?

Joseph Oliveto, the President and CEO of Milestone Pharmaceuticals, will be presenting.

How can I access the webcast of Milestone Pharmaceuticals' presentation?

The webcast can be accessed on Milestone's website in the News & Events section.

Where is Milestone Pharmaceuticals located?

Milestone Pharmaceuticals operates in Canada and the United States.

Will there be a replay available for Milestone Pharmaceuticals' presentation?

Yes, an archived replay of the presentation will be available for approximately 30 days after the event.
Milestone Pharmaceuticals

NASDAQ:MIST

MIST Rankings

MIST Latest News

MIST Latest SEC Filings

MIST Stock Data

145.64M
81.79M
Biotechnology
Pharmaceutical Preparations
Link
Canada
MONTREAL